Literature DB >> 2733732

Low levels of high-affinity growth hormone-binding protein in African pygmies.

G Baumann1, M A Shaw, T J Merimee.   

Abstract

The cause of growth hormone resistance and short stature in African Pygmies in unknown. Low levels of insulin-like growth factor 1 that fail to respond to growth hormone suggest a possible deficiency of growth hormone receptors. The high-affinity growth hormone-binding protein is a fragment of the growth hormone receptor and may be an indicator of the number of receptors in tissues. We measured growth hormone-binding activity in plasma from 20 pygmies and 12 control subjects (7 white Americans and 5 non-Pygmy black Africans of normal stature). Growth hormone binding to the high-affinity binding protein was significantly reduced in the Pygmies as compared with the controls (mean +/- SD, 6.50 +/- 2.33 percent vs. 12.95 +/- 3.95 percent bound per 160 microliters of plasma; P less than 0.001); however, there was substantial overlap between the values for Pygmies and controls. Growth hormone binding to the low-affinity binding protein was similar in Pygmies and control subjects. We conclude that Pygmies have low levels of high-affinity growth hormone-binding protein in their plasma, which may indicate a reduced number of growth hormone receptors in their tissues. The finding may help explain the resistance to growth in Pygmies, but there may be additional reasons, related to the receptors or not, for their short stature.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2733732     DOI: 10.1056/NEJM198906293202601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  9 in total

1.  Polymorphism and mapping of the IGF1 gene, and absence of association with stature among African Pygmies.

Authors:  A Bowcock; V Sartorelli
Journal:  Hum Genet       Date:  1990-08       Impact factor: 4.132

Review 2.  The relevance of pharmacokinetics in the development of biotechnology products.

Authors:  S Toon
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 3.  Circulating growth hormone binding proteins.

Authors:  G Baumann; M A Shaw; K Amburn
Journal:  J Endocrinol Invest       Date:  1994-01       Impact factor: 4.256

4.  The role of GHR and IGF1 genes in the genetic determination of African pygmies' short stature.

Authors:  Noémie S A Becker; Paul Verdu; Myriam Georges; Philippe Duquesnoy; Alain Froment; Serge Amselem; Yves Le Bouc; Evelyne Heyer
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

5.  Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

Authors:  J D Veldhuis; M L Johnson; L M Faunt; M Mercado; G Baumann
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

Review 6.  Short stature with normal growth hormone and elevated IGF-I.

Authors:  T Momoi; C Yamanaka; M Kobayashi; T Haruta; H Sasaki; T Yorifuji; M Kaji; H Mikawa
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

7.  Diversity among African pygmies.

Authors:  Fernando V Ramírez Rozzi; Marina L Sardi
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

8.  Whole-genome sequence analyses of Western Central African Pygmy hunter-gatherers reveal a complex demographic history and identify candidate genes under positive natural selection.

Authors:  PingHsun Hsieh; Krishna R Veeramah; Joseph Lachance; Sarah A Tishkoff; Jeffrey D Wall; Michael F Hammer; Ryan N Gutenkunst
Journal:  Genome Res       Date:  2016-02-17       Impact factor: 9.043

9.  Patterns of ancestry, signatures of natural selection, and genetic association with stature in Western African pygmies.

Authors:  Joseph P Jarvis; Laura B Scheinfeldt; Sameer Soi; Charla Lambert; Larsson Omberg; Bart Ferwerda; Alain Froment; Jean-Marie Bodo; William Beggs; Gabriel Hoffman; Jason Mezey; Sarah A Tishkoff
Journal:  PLoS Genet       Date:  2012-04-26       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.